Please assess the completion status of the following clinical trial:

Trial Title: An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged ≥ 20 years at the time of informed consent~* Japanese patients with type 2 diabetes~* Patients who have HbA1c ≥ 7.0% and \< 9.0%~Exclusion Criteria:~* Patients with type 1 diabetes mellitus or with a history of diabetic coma, precoma, or ketoacidosis~* Patients receiving or requiring treatment with insulin~* Patients with a body mass index (BMI) of \< 18.5 kg/m2 or ≥ 35.0 kg/m2~* Patients with clinically evident renal impairment (estimated glomerular filtration rate \[eGFR\] of \< 45 mL/min per 1.73 m2) or clinically significant renal disease~* Patients with fasting plasma glucose ≥ 240 mg/dL

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DS-8500a 75 mg once daily (QD) (Type: EXPERIMENTAL): tablets, orally, once daily for up to 28 days
- Placebo (Type: PLACEBO_COMPARATOR): tablets, orally, once daily for up to 28 days

Based on this trial design, predict the completion outcome and termination type (if applicable).